|
Symbol
|
BCSBIL | MABBJB | MAPTJB | ZMAH5V | MAQGJB | MAKGJB | LVCXLK | MAFQJB | MASEJB | AHHETQ | AHHCTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Barrier Express Certificate | Express Certificate | Express Certificate | Express Voncert* | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In |
|
Sous-jacent
|
Novartis AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé / Novartis / UBS / Zurich | Nestlé / Novartis / UBS / Zurich |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
02.10.2030 | 04.02.2028 | 04.02.2028 | 30.04.2029 | 30.04.2029 | 30.04.2029 | 12.08.2027 | 05.01.2029 | 05.01.2029 | 22.07.2030 | 22.07.2030 |
| Ratio | 0,0967 | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - | - |
| Demande | 100,91 | - | - | 98,70 | - | - | - | - | - | 99,59 | 100,01 |
| Offre | 101,72 | - | - | 99,70 | - | - | - | - | - | 100,39 | 100,81 |